PharmaResearch Spin-Off into Holding and Aesthetics Companies Approved by Board of Directors

SEONGNAM, South Korea, June 13, 2025 /PRNewswire/ — PharmaResearch announced on June 13 that its board of directors has approved a corporate spin-off, resulting in the formation of two distinct entities: PharmaResearch Holdings, which will remain as the surviving entity focused on investment and governance, and PharmaResearch, a newly established operating company that will continue to lead the aesthetics business.

The decision is part of a broader strategy to enhance operational efficiency and sharpen business focus by separating investment and commercial functions. PharmaResearch Holdings will serve as the group’s control tower, managing subsidiaries, directing M&A activities, and pursuing long-term value creation. The new PharmaResearch will concentrate on its core business areas—including medical devices, pharmaceuticals, and cosmetics—with the goal of accelerating growth in the global aesthetics market.

The spin-off ratio is 0.7427944 for PharmaResearch Holdings and 0.2572056 for the new PharmaResearch. Following the spin-off, total assets are expected to reach KRW 580.2 billion (approx. USD 427.2 million) for PharmaResearch Holdings and KRW 219.5 billion (approx. USD 161.6 million) for PharmaResearch.

The proposed spin-off will be finalized following shareholder approval at an extraordinary general meeting scheduled for October. If approved, the effective date will be November 1, 2025, followed by re-listing procedures for both entities.

A company spokesperson commented, "This spin-off will allow us to sharpen our competitive edge in each business segment and respond more swiftly to evolving global market dynamics. Transitioning to a holding company structure will establish a strong foundation for sustainable growth and deliver greater long-term value to our shareholders."

In a separate move to enhance shareholder value, PharmaResearch has also announced that it will cancel all of its treasury shares on June 20.

Source : PharmaResearch Spin-Off into Holding and Aesthetics Companies Approved by Board of Directors

The information provided in this article was created by Cision PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ThailandChina.